Correlation Between Mineralys Therapeutics, and Nuvation Bio
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Nuvation Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Nuvation Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and Nuvation Bio, you can compare the effects of market volatilities on Mineralys Therapeutics, and Nuvation Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Nuvation Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Nuvation Bio.
Diversification Opportunities for Mineralys Therapeutics, and Nuvation Bio
-0.51 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Mineralys and Nuvation is -0.51. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Nuvation Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvation Bio and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Nuvation Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvation Bio has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Nuvation Bio go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and Nuvation Bio
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to under-perform the Nuvation Bio. In addition to that, Mineralys Therapeutics, is 1.29 times more volatile than Nuvation Bio. It trades about -0.02 of its total potential returns per unit of risk. Nuvation Bio is currently generating about 0.25 per unit of volatility. If you would invest 234.00 in Nuvation Bio on August 31, 2024 and sell it today you would earn a total of 55.00 from holding Nuvation Bio or generate 23.5% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. Nuvation Bio
Performance |
| Timeline |
| Mineralys Therapeutics, |
| Nuvation Bio |
Mineralys Therapeutics, and Nuvation Bio Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and Nuvation Bio
The main advantage of trading using opposite Mineralys Therapeutics, and Nuvation Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Nuvation Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvation Bio will offset losses from the drop in Nuvation Bio's long position.| Mineralys Therapeutics, vs. Cue Biopharma | Mineralys Therapeutics, vs. Tff Pharmaceuticals | Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Inhibrx |
| Nuvation Bio vs. Assembly Biosciences | Nuvation Bio vs. Instil Bio | Nuvation Bio vs. Achilles Therapeutics PLC | Nuvation Bio vs. NextCure |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |